A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister image

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister

Feb 02, 2023
01:00PM - 02:00PM EST
Online Event
Overview

Dr. Craig Hofmeister, multiple myeloma specialist from Emory, presents an update on the role of CAR-T therapy in multiple myeloma. What products are currently FDA approved and what new products have been developed? Will the product become more widely available? Will it ever become front-line therapy? The answers to these questions and more will be discussed in this important meeting.

Agenda
01:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Stephanie Wiese.

01:05 PM
Presentation
Craig Hofmeister

Dr. Craig Hofmeister presents an update on the role of CAR-T therapy in multiple myeloma.

01:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Healthtree contact Craig Hofmeister

Craig Hofmeister

Craig C. Hofmeister, MD, MPH, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.